Evidence map›Paper›PMID 33918442›Full record

ArticleInternational journal of molecular sciences2021

Plant Extracellular Vesicles and Nanovesicles: Focus on Secondary Metabolites, Proteins and Lipids with Perspectives on Their Potential and Sources.

Eric Woith, Gea Guerriero, Jean-Francois Hausman, Jenny Renaut, Céline C Leclercq, Christoph Weise, Sylvain Legay, Alexander Weng, Matthias F Melzig

Abstract readEvaluation Study
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Valorization ofCells · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eric WoithFreie Universität Berlin, Institute of Pharmacy, Pharmaceutical Biology, Dahlem Center of Plant Sciences, Königin-Luise-Str. 2+4, D-14195 Berlin, Germany.ORCID 0000-0003-3457-0338
Gea GuerrieroLuxembourg Institute of Science and Technology, Environmental Research and Innovation Department, 5 rue Bommel, L-4940 Hautcharage, Luxembourg.ORCID 0000-0001-6586-6997
Jean-Francois HausmanLuxembourg Institute of Science and Technology, Environmental Research and Innovation Department, 5 rue Bommel, L-4940 Hautcharage, Luxembourg.ORCID 0000-0001-6103-7817
Jenny RenautLuxembourg Institute of Science and Technology, Environmental Research and Innovation Department, 41 Rue du Brill, L-4422 Belvaux, Luxembourg.ORCID 0000-0002-0450-3866
Céline C LeclercqLuxembourg Institute of Science and Technology, Environmental Research and Innovation Department, 41 Rue du Brill, L-4422 Belvaux, Luxembourg.ORCID 0000-0003-0565-4591
Christoph WeiseFreie Universität Berlin, Institute of Chemistry and Biochemistry, Core Facility BioSupraMol, Thielallee 63, D-14195 Berlin, Germany.ORCID 0000-0002-5507-4694
Sylvain LegayLuxembourg Institute of Science and Technology, Environmental Research and Innovation Department, 5 rue Bommel, L-4940 Hautcharage, Luxembourg.
Alexander WengFreie Universität Berlin, Institute of Pharmacy, Pharmaceutical Biology, Dahlem Center of Plant Sciences, Königin-Luise-Str. 2+4, D-14195 Berlin, Germany.ORCID 0000-0003-1640-2189
Matthias F MelzigFreie Universität Berlin, Institute of Pharmacy, Pharmaceutical Biology, Dahlem Center of Plant Sciences, Königin-Luise-Str. 2+4, D-14195 Berlin, Germany.

Funding

Fonds National de la Recherche Luxembourg C15/SR/10240550
6 · The paper itself

Abstract

While human extracellular vesicles (EVs) have attracted a big deal of interest and have been extensively characterized over the last years, plant-derived EVs and nanovesicles have earned less attention and have remained poorly investigated. Although a series of investigations already revealed promising beneficial health effects and drug delivery properties, adequate (pre)clinical studies are rare. This fact might be caused by a lack of sources with appropriate qualities. Our study introduces plant cell suspension culture as a new and well controllable source for plant EVs. Plant cells, cultured in vitro, release EVs into the growth medium which could be harvested for pharmaceutical applications. In this investigation we characterized EVs and nanovesicles from distinct sources. Our findings regarding secondary metabolites indicate that these might not be packaged into EVs in an active manner but enriched in the membrane when lipophilic enough, since apparently lipophilic compounds were associated with nanovesicles while more hydrophilic structures were not consistently found. In addition, protein identification revealed a possible explanation for the mechanism of EV cell wall passage in plants, since cell wall hydrolases like 1,3-

Indexed as

Secondary MetabolismCell Culture TechniquesCells, CulturedCraterostigmaExtracellular VesiclesMagnoliopsidaPhospholipidsProteomePhospholipidsProteomeexosome-like nanoparticlesextracellular vesiclesin vitro plant cell culturelipidsmetabolomicsplant nanovesiclesproteomics

Identifiers

PMID33918442
PMCPMC8038311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.